Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report

Abstract

<b><i>Introduction:</i></b> For primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT), there are no uniform recommendations for second-line treatment in case of relapse. <b><i>Case Presentation:</i></b> Here, we present the case of an elderly relapsed/refractory PCDLBCL-LT patient who obtained a prolonged clinical complete remission with lenalidomide. <b><i>Conclusion:</i></b> Lenalidomide as single agent led to an unexpected long complete response with manageable toxicity.